Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms

C A Belmokhtar1, J Hillion, E Ségal-Bendirdjian

  • 1INSERM U496, Centre G Hayem, Hôpital Saint-Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France.

Oncogene
|June 26, 2001
PubMed

Insights

Staurosporine induces apoptosis through two pathways: a rapid caspase-dependent one and a slower caspase-independent one. Cancer cells utilize these distinct apoptotic mechanisms differently, impacting drug sensitivity.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Anticancer therapy efficacy relies on inducing apoptosis in tumor cells.
  • Multiple signaling pathways regulate apoptosis, influencing cellular sensitivity to drugs.
  • Staurosporine is a known inducer of apoptosis across various cell lines.

Purpose of the Study:

  • To investigate the distinct apoptotic responses of L1210/S and L1210/0 cell sublines to staurosporine.
  • To elucidate the roles of caspase-dependent and caspase-independent pathways in staurosporine-induced apoptosis.
  • To understand the mechanisms underlying differential sensitivity of cancer cells to apoptosis inducers.

Main Methods:

  • Treatment of L1210/S and L1210/0 cells with staurosporine.
  • Utilizing a broad-spectrum caspase inhibitor (Z-VAD-fmk) to assess caspase involvement.
  • Monitoring and characterizing cell death timing and mechanisms (apoptosis).

Main Results:

  • Staurosporine induced rapid apoptosis in L1210/S cells (within 3 hours) and delayed apoptosis in L1210/0 cells (after 12 hours).
  • Caspase inhibition (Z-VAD-fmk) blocked early apoptosis in L1210/S cells but not late apoptosis in L1210/0 cells.
  • A secondary, caspase-independent apoptotic process was unmasked in L1210/S cells, and L1210/0 cells primarily undergo caspase-independent apoptosis due to defective caspase activation.

Conclusions:

  • Staurosporine triggers apoptosis via at least two redundant, parallel pathways: one caspase-dependent and one caspase-independent.
  • L1210/S cells possess both pathways, with the caspase-dependent pathway masking the caspase-independent one.
  • L1210/0 cells exhibit a defect in caspase activation, leading to reliance on the caspase-independent apoptotic pathway for staurosporine-induced cell death.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...